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Previous canine experiments suggested that transvenous
catheters placed in the coronary sinus could be used to
deliver limited energy shocks, resulting in fibrosis in the
atrial wall and coronary sulcus with sparing of the coro-
nary artery. From the distribution of the fibrosis, it
appeared that this approach could be used for attempted
ablation of accessorypathways in patients with the Wolff-
Parkinson-White syndrome.
Eight patients with symptomatic Wolff-Parksinson-
White syndrome underwent electrophysiologic testingwith
attempted ablation of 10 accessory pathways. Shocks
were limited to 40 to 80 J, except in one patient who
received shocks of 100 and 150 J. From 2 to 26 shocks
were given to each accessory pathway. All the accessory
pathways were blocked completely immediately after the
shocks. Subsequently, evidence of accessory pathway
conduction recurred in each patient. Three had early
promise of long-term improvement after the procedure,
with prolongation of the refractory periods of the ac-
There has been a recent surge of interest in internal cardiac
stimulation using energy sufficient for cardioversion, defi-
brillation and localized ablation of cardiac tissue (1-14),
Ablation of the atrioventricular (AV) conduction system
using shocks delivered through conventional or modified
multipolar electrode catheters appears to be a safe and ef-
fective technique for selected patients with drug-resistant
supraventricular tachycardia (5,7-8,13). The technique has
been applied successfully to ventricular tachycardia (9), and
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cessory pathways during the remainder of the initial
hospitalization. Several weeks later, however, there was
evidenceof return toward original values in two of these.
Another patient who appeared not to benefit during her
initial hospitalization returned 7 weeks later with very
depressed accessory pathway conduction, possibly due
to developing fibrosis. The only significant complication
occurred in the patient receiving shocks of 100 and 150
J; he had apparent rupture of the coronary sinus re-
quiring pericardial drainage. In two patients in whom
nonsurgical ablation was not successful, intraoperative
mapping showed that the accessory pathway was located
in an area of fibrosis at the site of the attempted ablation.
In summary, nonsurgical electrical ablation of ac-
cessory pathways via the coronary sinus may be suc-
cessful using limited energy levels in a few patients. The
procedure remains experimental, and widespread ap-
plication must await more effective means of delivering
the shocks.
septal accessory (Kent) pathways have been ablated
(5,10,12,14).
In patients with the Wolff-Parkinson-White syndrome,
arrhythmias relevant to the accessory pathway include rapid
anterograde conduction of atrial fibrillation, and AV recip-
rocating tachycardia. In the latter, the accessory pathway is
usually used for retrograde conduction, and the normal path-
way for anterograde conduction. The rationale for treatment
in both instances is to block or increase the refractoriness
in the accessory pathway, thereby preventing or slowing the
conducted arrhythmia.
In patients with the Wolff-Parkinson-White syndrome.
the accessory pathway may lie in close proximity to the
coronary sinus (15,16). Extensive canine experiments in our
laboratory (17) demonstrated that limited energy levels de-
livered to the coronary sinus could result in histopathologic
changes likely to involve the accessory pathway, but sparing
0735-1097/84/$3.00
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Figure 1. Schematic representation of the effects of attempted
electrical ablation of accessory pathways by way of the coronary
sinus, Cross section of the left posterior heart, showing the left
atrium (LA) (above), with the endocardium to the right and the
epicardium to the left; the left ventricle (LY) (below), with the
mitral valve (MY) anulus, circumflex coronary artery (Cx) and
coronary sinus (CS) in the middle, The heavy lines represent the
locations of possible accessory pathways, Coronary sinus shocks
in canine experiments (17) resulted in damage and fibrosis to the
hatched area with sparing of the coronary artery,
the coronary artery (Fig. 1). This technique has now been
applied to symptomatic patients with the Wolff-Parkinson-
White syndrome with left-sided accessory pathways ap-
proached via the coronary sinus. This paper is not intended
to report in detail the conventional management data of the
patients involved, but rather to address the question of whether
accessory pathways in proximity to the coronary sinus can
be ablated safely using the techniques described.
Methods
Patients. Eight patients were studied after giving in-
formed consent to a protocol approved by the Institutional
Review Board at Montefiore Hospital. The highly experi-
mental nature of the procedure was carefully explained,
along with the alternatives of conventional and experimental
medications or surgical ablation for those with drug-resistant
or life-threatening arrhythmias, Their ages ranged from 18
to 54 years. All had either overt Wolff-Parkinson-White
syndrome with symptomatic tachycardia related to accessory
pathway conduction, or tachycardia due to retrogradely con-
ducting accessory pathways (Table 1), All had failed to
respond to one to six (mean three) antiarrhythmic drugs.
Patients 1, 4, 5 and 7 had syncope; Patients 2, 6 and 8 had
near syncope. Patient 2 had ventricular rates approaching
300 beats/min during atrial fibrillation with lightheadedness
and chest pain. Patient 3 had 20 to 40 episodes oftachycardia
per day in spite of multiple drug trials. Patient 5 had severe
mitral stenosis, recurrent after a previous valvotomy. A
variety of medications had failed to control her episodes of
Table 1. Clinical Summary of Eight Patients Before and After Ablation
Patient no, (age [yrl/sex) Patient I (191 F) Patient 2 (41/M) Patient 3 (231M) Patient 4 (26/F)
Clinical Arrhythmia AF AF,AVT AVT AVT
Before After Before After Before After Before After
Frequency of episodes
Without drugs I to 2/mo 0 o to 5/mo 0 20 to40/day 8 to 20/day limo (O)t
With drugs* I to 2/mo 0 o to 5/mo 0 20 to40/day o to I/day limo 0
Severity of episodes
Without drugs
Palpitation + 0 + (0) + + + (O)t
Syncope + 0 Near (0) 0 0 + (O)t
WIth drugs
Palpitation + 0 + 0 + + + +
Syncope + 0 0 0 0 0 + 0
Drug treatment
Ineffective DPH§ P Q,D N,PA,P V,PA D.Q.D+Q,P PA
Effective N,NM N,PA V+D PA+V,N
Follow-up (mo) 25 24 21 19
Associated conditions 0 0 0 0
*Most effective regimen. tNoepisodes during I week offdrugs before latest follow-up. tSevere congestive heart failure was the most serious problem;
patient underwent surgery 8 weeks after attempted ablation (see text). §Patient was treated with phenytoin for several years because of syncopal spells
attributed toepilepsy; full neurologic work-up negative. ~Aprindine discontinued because ofsevere hepatotoxicity. AF = atrial fibrillation with anterograde
conduction over accessory pathway; After = after ablation; AP = aprindine; AVT = atrioventricular tachycardia (the typical reciprocating tachycardia
of the Wolff-Parkinson-White syndrome); Before = before ablation; CAD = coronary artery disease (Patient 6 postinfarction, not a surgical candidate;
Patient 7 has a proximal left anterior descending coronary artery obstruction, angioplasty done or possible surgery for both Wolff-Parkinson-White
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atrial fibrillation, conducted at rates up to 200 beats/min
and causing profound hemodynamic decompensation. Al-
though mitral valve replacement was planned, nonsurgical
ablation was attempted so that, if successful, operative time
would be reduced.
Cardiac catheterization. This procedure with coronary
arteriography was recommended in all patients, and man-
datory after the third patient, primarily to assess the relation
between the coronary sinus and the left circumflex coronary
artery Although canine data suggested a minimal risk of
coronary artery damage from coronary sinus shocks (17),
it was decided not to attempt an ablation where the two
vessels were in proximity. Three additional potential can-
didates were excluded because the accessory pathway was
adjacent to a large circumflex artery.
Exercise testing. This test, using a bicycle ergometer.
was performed before electrophysiologic studies and at in-
tervals thereafter. The shortest ventricular cycle length re-
sulting from accessory pathway conduction was recorded
as the anterograde accessory pathway conduction limit.
Electrophysiologic studies. These were carried out in
a conventional manner, with percutaneous insertion of mul-
tipolar catheters under local anesthesia. The effective and
functional refractory periods of the normal and accessory
conduction pathways were assessed, when possible, using
atrial and ventricular programmed stimulation during sinus
rhythm and pacing. The shortest pre-excited ventricular cycle
lengths (conduction limits) were recorded during atrial fi-
brillation when observed. Anterograde accessory pathway
Table 1. (continued)
conduction limits were determined in all patients during
incremental ramp atrial pacing (18). The shortest pre-excited
atrial cycle length during incremental ramp ventricular pac-
ing was recorded as the retrograde accessory pathway con-
duction limit. Incremental ramp pacing employed a contin-
uously increasing pacing rate, increasing from 80 beats/min
in increments of approximately 2 beats/min every second.
In some instances, the refractory periods and conduction
limits could not be measured because of the induction of
fibrillation or tachycardia, or during exercise because ac-
cessory pathway conduction persisted up to the maximal
heart rate achieved. In these instances, a "less than" symbol
«) was recorded. Atrial stimulation was performed at sev-
eral sites in the right atrium and in the left atrium via the
coronary sinus. All stimuli were delivered using a De-
vices/Digitimer 4279 modular pacing system, with outputs
at four times diastolic threshold and 1 ms pulse duration.
Electrophysiologic studies in these patients were contin-
ued over several days using an electrode catheter that re-
mained in the coronary sinus. Therefore, the anterograde
conduction intervals and refractory periods reported in the
study are based on coronary sinus stimulation. In Patients
3, 4 and 8. a second catheter lead was left in the right
ventricle for determination of retrograde refractory periods
and conduction limits.
lntracardiac bipolar mapping was performed to deter-
mine activation sequence during pacing, and during regular
tachycardia if induced. Atrial mapping was performed dur-
ing retrograde conduction using catheters situated at the high
Patient 5 (37/F)
AF
Patient 6 (54/M)
AVT
Patient no. (age [yr]/sex)
Cl mical Arrhythmia
Frequency of episodes
Without drugs
WIth drugs*
Seventy of episodes
Without drugs
Palpitation
Syncope
With drugs
Palpitation
Syncope
Drug treatment
Ineffective
Etfective
FoIl11W-UP (100)
Ass, l( rated conditions
Before
2 to 3/100
o to 3/100
D,P,PA,N,Q
AI1I
After
(0)
(0)
(0)
(0)
(0)
15
RHD
Before
Daily
8 to 40/100
+
Near
+
Near
D,P,PA,V
After
Daily
o to 2/100
+
o
o
o
D,P,PA,V
D+PA+V
6
CAD
Patient 7 (36/F) Patient 8 (l8/F)
AF AVT
Before After Before After
(I) (0) 4/100 (0)
(0) (0) 4/100 (0)
+ (0) + (0)
+ (0) Near (0)
(0) (0) + (0)
(0) (0) 0 (0)
PA,Q PA,P
(PA) PA
4 4
CAD 0
syndrome and coronary artery disease if both nonsurgical treatments fail); D = digoxin; DPH = diphenylhydantoin (phenytoin); F = female; M =
male, 100 = month; N = disopyramide; NM = no medicattons needed; P = propranolol; PA = procainamide; Q = quinidine; RHD = rheumatic
hean disease with severe mitral stenosis (Patient 5 underwent surgical treatment for both mitral stenosis and Wolff-Parkmson-White syndrome [see textl);
V = verapamil; + = present; 0 = absent; (0) = limited data or brief trials only. Parentheses after patient number indicate the patient's age (in years)
and gender.
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right atrium, His bundle area and multiple sites around the
tricuspid anulus using a Gallagher (modified Brocken-
brough) catheter (15); left atrial mapping was performed
using a catheter advanced as far as possible into the coronary
sinus and withdrawn in a stepwise fashion during each
tachycardia or pacing condition. In Patients 5 to 8, a hex-
apolar or octapolar catheter with 8 to 10 mm interelectrode
spacing (Cordis, USCI) permitted mapping in the coronary
sinus without moving the catheter . The site of earliest an-
terograde ventricular activation was determined during sinus
rhythm and atrial pacing using catheters in the same sites
as used for atrial mapping. Mapping data were interpreted
from the interval from the pacer stimulus or onset of atrial
or ventricular depolarization to the peak local deflection in
the ventricle or atrium, respectively , for anterograde and
retrograde conduction.
Ablation of the accessory pathway. This procedure was
attempted through the electrodes at the estimated site of the
accessory pathway recording the shortest conduction inter-
val. Additional shocks to distal or proximal sites, or both,
were delivered in Patients 2 to 5 and 7 and 8 (see Results).
The patients were anesthetized with methohexital (Brevital)
and paralyzed by succinylcholine to prevent laceration of
the coronary sinus due to skeletal muscle stimulation. Bi-
polar shocks were used in Patients I to 4 and 7 and 8 and
unipolar shocks were used in Patients 5 and 6. Unipolar
shocks were cathodal , with anodal plates on the upper an-
terior chest and abdomen. In Patients I and 2, asynchronous
shocks were provided by an Electrodyne C-IOOM defibril-
lator. Synchronous shocks were delivered in subsequent
patients by a Physic-Control Lifepak 911. Multichannel sur-
face and intracardiac recordings were made continuously
during the procedure. The number and energy of the shocks
varied depending on effects and with increasing experience
as discussed in the Results section.
Other procedures and methods. Twelve lead electro-
cardiograms included multiple baseline recordings before
the procedure, intermittent records during the electrophys-
iologic study, every 12 hours the next day and daily re-
cordings thereafter during the hospitalization. Twenty-four
hour electrocardiographic (Holter) recordings were made in
each patient , both before and after the attempted ablation
procedure. Blood was drawn for cardiac enzyme levels two
or more times before the ablation attempt and afterwards at
2 hours and then every 12 hours for 3 days
Attempted ablation procedures were performed in the pres-
ence ofa cardiothoracic surgeon and with the help of senior
members of the Anesthesiology Department. An operating
room was available; the first two patients were observed in
the recovery room for several hours after the procedure to
facilitate rapid transport to the operating room in the event
of hemodynamic embarrassment suggestive of rupture.
Thereafter, the patients were transferred initially to the coro-
nary care unit and subsequently to the intermediate care unit
and general medical wards.
Follow-up. The refractory periods or conduction limits.
or both, of normal and accessory pathways were determined
both immediately after the ablation attempt and during the
succeeding days. Patients I to 5 and 8 were evaluated 6 to
9 weeks after the procedure with a careful physical exam-
ination, electrocardiogram and exercise test, all in the ab-
sence of antiarrhythmic medications . Patients 4, 5 and 8
underwent a repeat electrophysiologic study without at-
tempted ablation 9, 8 and 6 weeks, respectively, after the
initial study.
Results
An overall clinical summary is provided in Table I.
Baseline electrocardiographic and exercise data. In
Patients I , 2, 4, 5 and 8, delta waves were present contin-
uously in each of multiple electrocardiograms recorded be-
fore the procedure, including the 24 hour tapes . Delta waves
were occasionally absent in Patient 7 and were visible in
Patient 3 primarily during sinus rates below 75 beats/min .
Baseline exercise tests were , therefore, not performed in
Patient 3; in addition , Patients 5 and 6 were too ill to undergo
baseline exercise testing. Delta waves persisted throughout
the exercise tests in Patients I, 2, 4 and 8, who exercised
to maximal rates of 188, 175, 175 and 180 beats/min , re-
spectively. An exercise test in Patient 7 showed delta waves
throughout to a rate of 177 beats/min, at which point she
developed an irregular wide complex tachycardia at 300
beats/min; exercise testing was not repeated after the at-
tempted ablation pending coronary revascularization.
Electrophysiologic data before attempted ablation
(Table 2). Patient 3 had poor anterograde accessory path-
way conduction with all refractory periods in excess of 600
ms. Delta waves were never observed in Patient 6. The
anterograde functional refractory periods for Patients I , 2,
5, 7 and 8 ranged between 250 and 300 ms; for Patient 4,
the functional refractory period could not be measured be-
cause of tachycardia induction. The shortest cycle length
during atrial fibrillation was shorter , ranging from 160 to
290 ms in Patients 2, 4,5 and 8. The ramp conduction limit
was generally similar to the extrastimulus functional re-
fractory period, except in Patient 2, in whom it was more
comparable with the conduction limit observed during atrial
fibrillation.
Retrograde conduction through the accessory pathway
was present in Patients 2,3,4,6 and 8 and absent in Patients
I and 5. Patient 7 had retrograde conduction only through
a lateral pathway with a long refractory period that was not
subjected to a shock. Retrograde ramp conduction limits
tended to be shorter than the functional refractory period.
Left-sided accessory pathways were identified by retro-
grade or anterograde mapping in each of these patients (Fig.
2). In Patients 3, 4 and 7, there was evidence of two left-
sided accessory pathways.
Table 2. Refractory Periods and Conduction Limits of Accessory Pathways
Anterograde Retrograde
Refractory Conduction Limits Refractory Conduction Limits
Periods (rns) (minimal RR) (ms) Periods (ms) (minimal AA) (ms)
ERP* FRP AF Ramp Exercise ERP FRP Ramp
Panen: 1
Baseline 260 280 290 <320 Block Block Block
After shock
Immediately Block Block Block Block Block Block
0,') to 1.0 h 330 Block Block Block
7 wk 400 to 500
7 mo 330 to 500
13 mo <330
Patient zt
Baseline 240 280 200 215 <340 220 300 260
After shock
Immediately Block Block Block Block Block Block
(: 5 to 1.0 h <250 260
~ days 230 275 <400
«wk <340
Patient 3
Baseline >600 >600 >600 340 350 310
After shock]
Immediately >600 >600 >600 Block Block Block
115 to 1.0 h >600 >600 >600 Block Block Block
\0 days >600 >600 >600 >650 270 300 290
Patient 4t
Baseline <300 <300 160 <300 <340 <270 <280
After shock
Immediately Block Block Block Block Block Block
) 5 to 1.0 h 270 Block Block Block
6 days 270 <280 <320 <280
'I wk <250 <280 235 <280 <375 AF AF AF
Patient 5
Bsselme 290 300 290 320 Block Block Block
A'ter shock
Immediately Block Block Block Block Block Block Block
0,5 to 1,0 h 410 410 410 Block Block Block
,~ days 300 330 300
H wk 260 320 290
Paticnt S
Baseline Block Block Block Block Block <220 <280 <240
After shock
Immediately Block Block Block
1),5 to 1,0 h Block Block Block
Patient 7
Baseline 270 290 290 <340 500§ 520§ 480§
After shock
Immediately Block Block Block
0.5 to 1.0 h 310 310 330
7 days 310 310 295
Patient 8
Baseline 200 250 230 260 <330 230 270 270
Alter shock
Immediately Block Block Block Block Block Block Block
0.5 to I 0 h 220 310 310
5 days 270 285 300 <370 280 305 275
6wk 240 275 230 200 200 240
*Effectiveand functional refractory periods (ERP and FRP. respectively) during pacing at cycle length 500 to 600 ms, except Patient 4 at 9 weeks
(430 rns), Patient 5 (410 to 440 ms) and Patient 8 (400 ms): all were in an unmedicated state, except Patient 5 who required propranolol to prevent
incessantatrial fibrillation. tIn Patients 2 and 4, refractorypenods were difficultto assess because of exquisiteease of tachycardiaand inductionof atrial
fibrillation. :j:In Patient 3, intermittentdelta waves were observeddunng sinus rhythm in the basehne state, but never after attemptedablation. §Retrograde
conductionover a distal accessory pathway, remote from that conducting anterogradely; because of a long refractory period, no shocks were directed at
thl' distal pathway. - = no data available; AF = atrial fibrillation (numbers are shortest consecutive preexcited RR interval during atrial fibrillation
[see definitions of conduction limits]; Conduction hrmts: anterogradeconduction limit = shortest consecutive preexcited RR interval (ventricularcycle
length) during atnal fibrillation, incremental atrial ramp pacing and exercise; retrograde conduction hmn = shortest consecutive preexcited AA interval
during ventricularpacing.
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PATIENT 4
PATIENT 2
PATIENT 3
PATIENT 1
4. In Patients 2, 3 and 4, the catheter lead position was
moved 0.5 to I em between shocks to create a modest
overlap at three accessory pathway sites (Fig. 4). In Patient
4, the polarity of shocks was alternated. In Patient 3, a more
lateral pathway could not be "bracketed"; that is, the ear-
Figure 4. Schematic location, energy and polarity of bipolar shocks
used in four patients. The heart is sectioned at the plane between
the atria and the ventricles, and is viewed from behind and above.
The mitral valve (MV) and tricuspid valve (TV) are illustrated
with the ostium of the coronary sinus visible in the lower left
corner of the tricuspid valve ring leading into the coronary sinus
which lies posterior to (below) the mitral valve. Site X of accessory
pathways is based on intracardiac mapping. (+) and ( - ) indicate
polarity of bipolar shocks delivered in the coronary sinus and the
numbers indicate the joules delivered. The heavy lines indicate
the position and sequence (top to bottom) of the bipolar shocks.
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Attempted ablation of accessory pathways. After
achievement of satisfactory anesthesia, shocks were deliv-
ered to catheter electrodes placed at the estimated site of
the accessory pathway. In all of these patients, the accessory
pathways lost the ability to conduct immediately after the
shock (Table 2, Fig. 3). Variations in technique resulted in
three groups.
Group1: bipolarshockstightlycenteredon theaccessory
pathway site (Patients 1 to 4) (Fig. 4). One to six bipolar
shocks with energies ranging between 60 and 80 J (deliv-
ered) were used on each pathway identified in Patients 1 to
Figure 2. Patient 5. Mapping and anterograde ramp conduction
limits of the left-sided accessory pathway. Peripheral leads I and
V I are displayed, together with recordings from the high right
atrium (RA), His bundle area (HBE) and multiple bipolar record-
ings from an octapolar catheter with electrodes 8 mm apart, all
located in the coronary sinus (CS) with leads I and 2 (not shown)
most distal. During incremental ramp pacing at a cycle length
(PCL) of 320 ms, accessory pathway conduction ceases, with
normalization of the QRS pattern. This represents the anterograde
ramp conduction limit of the accessory pathway. The vertical
dashed line shows the earliest local ventricular activation during
anomalous conduction recorded on coronary sinus leads 5 and 6,
100 ms after the pacer stimulus in coronary sinus leads I and 2.
The time from the stimulus to local ventricular activation is in-
dicated (in ms) by the horizontal arrows.
I ' I I sec
I ----f~ '-..-- .
<:::::=' ~ ...--
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Figure 3. Patient 2. Normalization of the electro-
cardiogram during attempted ablation of the acces-
sory pathway. The electrodes at the proximal coro-
nary sinus (PeS) are connected to the defibrillator
rather than the recording device, and a shock of 80
J (loo stored) is delivered asynchronously during
sinus rhythm, with normalization of conduction and
prolongation of the HV interval to normal. Periph-
eralleads I, II and V I are displayed, together with
recordings from the His bundle region (HBE), mid
coronary sinus (MCS) and distal coronary sinus
(DCS).
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liest depolarization was recorded from the most distal po-
sition to which the catheter could be advanced (Fig. 5).
Group 2: unipolar shocks (Patients 5 and 6). Patient 5
received a total of 26 unipolar shocks of 40 to 50 J: 6 each
through electrodes 4, 5, 6 and 7 of the octapolar lead, and
2 throughelectrode 8. The accessorypathwayin this patient
appeared to be nearest to electrodes 5 and 6 (Fig. 2). It was,
therefore, intended to distribute the shocks in an area cen-
tered around the estimated site of the accessory pathway.
For half of these shocks, the anode was a large adhesive
plate on the upper anteriorchest; for the other half, a similar
plate was positionedon the upper anterior abdomen. In this
patient, there was also immediatenormalization of the QRS
complex.
Patient 6 received two unipolar shocks of 150 and 100
J, respectively, centered at the accessory pathway site. Block
immediately occurred in this pathwaylocatedat the junction
of the proximal and middle thirds of the coronary sinus.
However, the patient developed cardiac tamponade and re-
quired immediate pericardial drainage, which restored him
to a stable condition.
Group 3: bipolar shocks distributed around the accessory
pathway site (Patients 7 and 8). Five shocks of 75 J were
administeredin Patient 7. These were distributedover 3 em
centered around her accessory pathway located at the junc-
tion of the proximal and middle thirds of the coronarysinus
and resulted in immediate block in the pathway.
FigureS. Patient 3. Summary of mapping show-
ing evidence of double accessory pathways. Pe-
ripheral leads I, II and VI are shown, together
with recordings from theproximal coronary sinus
(PeS), His bundle area (HBE), mid coronary sinus
(MCS) and distal coronary sinus (DCS). In these
illustrations, ventricular activity (V) precedes atrial
depolarization (A) during normodromic tachy-
cardia. Left panel, Tachycardia at a cycle length
of 310 ms. The vertical dashed lineindicates that
the first atrial depolarization occurs in the mid
coronary sinus lead. Right panel, Tachycardia
with initial atrial depolarization in thedistal coro-
nary sinus. The cycle length is longer at 380 ms
because of slower AV nodal conduction rather
than to a longer circuit length (see text). In both
tachycardias, anterograde conduction is through
thenormal pathway, with normal QRS complexes
each preceded bya His bundle potential (H) . The
tachycardia using the distal coronary sinus path-
way is terminated by a ventricular extrastimulus
(arrow pointing down) delivered 220 ms after
the preceding ventricular event. Labeling on the
distal coronary sinus lead indicates that the ex-
trastimulus delivered to the right ventricle was
conducted to the left ventricle with some delay,
resulting in a VV interval of 300 ms as recorded
from lead DeS; this was sufficient to terminate
the tachycardia due to retrograde block (absence
of the atrial depolarization indicated by the X).
The accessory pathway in Patient 8 was located in the
region of the proximal coronary sinus. Five shocks of 50 J
were distributed over a 2 cm range and produced block in
the accessory pathway. When delta waves reappeared after
15 minutes, four additional unipolar shocks of 300 J were
delivered in the right atrium to posterior septal sites in prox-
imity to the ostium of the coronary sinus, and again produced
transient block.
Electrophysiologic data after attempted ablation of
accessory pathway (Table 2). Incremental ramp pacing
was carried out periodicallyduring the hour after attempted
ablation and on succeeding days to estimate conduction
limits. Refractory period determinations using the extra-
stimulus technique were also used during this period. As
notedpreviously and outlined in Table 2, all accessorypath-
ways subjected to attempted ablation were blocked in each
patient immediately after the procedure. During the next
hour, there was a gradual return of accessory pathway con-
duction in six patients, although refractory periods were
often markedly prolonged compared with baseline values
(Fig. 6). Assessment of refractory periods or conduction
limits, or both, was carried out again 4 to 10 days after the
attempted ablation procedure in six patients (Patients 2 to
5, 7 and 8), by which time only Patients 2 and 8 showed
persistence of prolonged refractory periods or conduction
limits. All of these patients were subsequently given an-
tiarrhythmic drug therapy, with serial electrophysiologic
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Figure 6. Patient 5. Sequential changes in accessory pathway
conduction during the attempted ablation procedure. Peripheral
leads I and V I are shown, together with recordings from the right
atrium (RA) and His bundle areas (HBE). Modified ramp pacing
was used, with the cycle length maintained for purposes of illus-
tration. All pacing stimuli (vertical arrows) were delivered in the
distal coronary sinus. A, Baseline recording before attempted abla-
tion. During pacing at a cycle length of 320 ms, there is occasional
failure of accessory pathway conduction. B, Immediately after
attempted ablation, there is no evidence of accessory pathway
conduction, with normalization of the QRS interval and Wenck-
ebach conduction at the AV node level during pacing at a cycle
length of 450 ms. C, One hour after attempted ablation, there has
been some return of accessory pathway conduction. However,
block in the accessory pathway occurs during pacing at a cycle
length of 410 ms.
testing to determine the best regimen for prevention of
tachycardia induction or prolongation of the accessory path-
way refractory periods.
Exercise testing after attempted ablation procedure
(Table 2). Five patients underwent exercise testing after
attempted ablation while receiving no antiarrhythmic med-
ications. In Patient 3, delta waves were seen only inter-
mittently during slow sinus rhythm before ablation and not
at all after the attempted ablation. In Patients 2, 4 and 8,
delta waves persisted during exercise tests performed both
several days and from 6 to 9 weeks (Patients 2 and 4) after
attempted ablation. In Patient 1, whose delta waves had
returned almost immediately after the attempted ablation
procedure, the course was different. Before the procedure,
her delta waves had persisted during multiple electrocar-
diograms, Holter recordings and exercise testing. She re-
turned for exercise testing 7 weeks after the procedure, and
in the absence of medication (confirmed by drug blood lev-
els), delta waves became intermittent with exercise at rates
greater than 100 beats/min and were gone entirely at rates
above 120 beats/min. Repeat exercise testing ,at 7 and 13
months, however, showed a progressive increase in the rates
associated with persistent delta waves during exercise.
Clinical course. The procedure was well tolerated by
all except Patient 6, who required surgical intervention for
cardiac tamponade. Patients 3 and 4 complained of peri-
cardial-type pain for several days without objective findings.
There were no other complications. Serial electrocardio-
grams were recorded for 3 days and were entirely normal
in Patient 1, whose QRS complexes were normalized by
disopyramide. There were no sequential electrocardio-
graphic changes suggestive of myocardial injury. Cardiac
enzymes, including creatine kinase-MB, were normal as
recorded 2 hours after attempted ablation and then every 12
hours for 3 days except in Patient 8 who received 300 J
septal shocks. All patients promptly returned to their usual
state of health and physical activity, except Patient 6, whose
recovery was slower.
Follow-up. At the time of this writing, Patient 1 has
been free of symptoms for the 25 months after her procedure
with medications discontinued after the first 4 weeks. Pa-
tients 2 to 4 were successfully treated with antiarrhythmic
drugs (Table 1). Patient 3, one of those with double acces-
sory pathways, continued to have frequent episodes of
tachycardia while taking no medications. However, the typ-
ical rate of his episodes was reduced from 180 to 140
beats/min. These slower tachycardias may have been due
to longer AV nodal conduction (Fig. 5). Consistently slower
tachycardias could also be related to damage to his accessory
pathways or successful ablation of his more medial pathway,
with slower tachycardia due to a longer circuit involving
the more lateral pathway.
Patient 5 underwent her scheduled operative procedure
for mitral valve replacement 8 weeks after the attempted
ablation procedure. On the day before operation, electro-
physiologic testing revealed no evidence of refractory period
prolongation in the accessory pathway (Table 2). Intra-
operative mapping was performed to locate the Kent bundle
for surgical division. It was noted that the entire atrium was
large and diffusely fibrotic, appearing pearly gray in color
rather than pink. Intraoperative mapping identified the same
location for the Kent bundle as predicted from mapping in
the catheterization laboratory. Careful inspection of the
coronary sulcus contents at this point revealed considerable
fibrosis and occlusion of the coronary sinus consistent with
the findings in the animal studies (17) (Fig. 1). After the
operation, there was no further evidence of accessory path-
way conduction, either clinically or during electrophysio-
logic studies.
Patient 6 is being followed up and may require surgery;
he is not tolerating medications well. Patient 7 underwent
successful coronary angioplasty and is receiving medical
therapy for arrhythmia prophylaxis. Patient 8 was readmit-
ted after 6 weeks to assess the long-term effects of attempted
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ablation. Refractory periods and conduction studies were
similar to baseline values, and he underwent successful sur-
gical division of his anomalous pathway. As in Patient 5,
the pathway was located at the site predicted during the
electrophysiologic testing, together with fibrosis resulting
from the attempted ablation procedure.
Discussion
The possibility of a nonsurgical "cure" of the Wolff-
Parkinson-White syndrome is attractive because it would
free patients from life-long dependence on medications and
require a shorter convalescence than would surgical ap-
proaches. The procedures described in this study were per-
formed after a series of canine experiments (17) had dem-
onstrated that limited energy bipolar shocks delivered to the
coronary sulcus could result in desirable degrees of fibrosis
without affecting the circumflex coronary artery.
Limited efficacy of the procedure. In this series, at-
tempted nonsurgical ablation of left-sided accessory path-
ways resulted in complete but transient block of accessory
pathways in each patient. Patient 1 has had a favorable long-
term effect, being free of recurrent episodes without med-
ications for 2 years. In Patient 2, the accessory pathway
refractory periods may have been permanently prolonged.
In Patient 3, recurrent tachycardias in the unmedicated state
are slower and better tolerated, but this may be due to slower
AV nodal conduction (Fig. 5), rather than to ablation of
one of his two accessory pathways. Patients 4 to 8 have not
derived apparent benefit from their attempted ablation pro-
cedures. There was one important complication in this group
of patients (cardiac tamponade in Patient 6), apparently due
to rupture of the coronary sinus and requiring surgical
intervention.
Exercise studies performed before electrophysiologic
studies accurately predicted refractory periods shorter than
the shortest exercise cycle length (19). Very short refractory
periods are better defined by electrophysiologic testing or
isoproterenol infusion (20). Serial exercise testing in Patient
1 has shown progressive shortening of the long postablation
accessory pathway conduction limit, although arrhythmias
have not yet recurred.
Technical considerations. There may be several rea-
sons for the limited efficacy of the procedure. Successful
ablation of the normally located AV conduction system or
sites of ventricular tachycardia has required shocks of sev-
eral hundred joules (5-10). In all but one of our patients,
shocks were limited to 80 J or less to minimize the possibility
of rupturing the coronary sinus. During the canine studies
in our laboratory (17), rupture of the coronary sinus with
subsequent exsanguination occurred with energies in excess
of 200 J. Apparent rupture of the coronary sinus occurred
in Patient 6, the only patient to receive higher energy shocks
of 100 and 150 J. Even at these energy levels, block of the
accessory pathway was transient.
Ablation techniques performed within the cardiac cham-
bers (5-14) have used unipolar shocks to "direct" the en-
ergy at the target tissues, using an anodal plate applied to
the skin. The variability of possible Kent bundle locations
with respect to the coronary sinus suggested that bipolar
shocks, given between two adjacent electrodes on a mul-
tipolar catheter, might be more effective for use in left-sided
accessory pathway ablation. The canine experiments (17)
appeared to confirm this supposition, with a near ideal dis-
tribution of fibrosis within the coronary sulcus. Subsequent
canine studies using unipolar shocks suggested that the ef-
fects would be similar to those from bipolar shocks. Bipolar
shocks were used in Patients 1 to 4 and 7 and 8; unipolar
shocks were used in Patients 5 and 6. The proportionately
larger hearts in human subjects may have prevented suffi-
cient energy from reaching the accessory pathways. Never-
theless, we are concerned about the possibility of coronary
artery damage and have adopted a policy of requiring an-
giography before attempted left-sided accessory pathway
ablation. We decided not to recommend an attempted abla-
tion procedure for three patients because coronary angiog-
raphy demonstrated the presence of a dominant left coronary
artery circulation.
Other observations. In the long-term canine studies (17),
catheterization and angiography several weeks after the shocks
were entirely normal except for coronary sinus occlusion
with development of profuse collateral vessels. Asympto-
matic coronary sinus occlusion was confirmed in two of our
patients 8 to 9 weeks after attempted ablation. Coronary
sinus occlusion prevents subsequent attempts at ablation
after initial failure. Catheter leads were left in the coronary
sinus for electrophysiologic studies on the days after at-
tempted ablation; however, concerns for the integrity of the
recently damaged vessel prevented further ablation attempts
after the reappearance of accessory pathway conduction. It
should be noted that electrode catheters generally are not
designed for use in ablation procedures, and many cannot
withstand the high energy levels involved (21). Examples
of the lead models to be used in any ablation procedure
should be tested first in vitro.
Conclusions. Electrical ablation of accessory pathways
using the coronary sinus approach was attempted in eight
patients, with initially promising but usually transient re-
sults. In some patients, several weeks may be required for
the development of the full affect, possibly related to a
maturing fibrotic process involving the pathway. The tech-
nique appears to be safe at energy levels below 100 J.
Unfortunately, shocks at these levels have not proved very
effective in creating permanent accessory pathway block,
and higher levels carry a substantial risk of perforating the
coronary sinus. If successful in even a minority of patients,
the benefits of a nonsurgical "cure" or a lessened require-
ment for antiarrhythmic medications might make the pro-
cedure useful. Nevertheless, the limited efficacy and the
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complications of the technique described in this paper em-
phasize the experimental nature of the procedure and the
need for much further development before widespread ap-
plicat ion can be contemplated.
We gratefully acknowledge the help of the participating fellow s and the
staff of the cardiac catheterization laboratory , the referrin g physicians and
the skillful contributions of Rob in L. Simak .
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